Filing Details

Accession Number:
0001209191-18-043367
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-19 17:06:28
Reporting Period:
2018-07-17
Accepted Time:
2018-07-19 17:06:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
917520 Integra Lifesciences Holdings Corp IART Laboratory Analytical Instruments (3826) 510317849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187574 Stuart Essig 311 C Enterprise Drive
Plainsboro NJ 08536
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-17 31,353 $21.12 1,450,272 No 4 M Direct
Common Stock Disposition 2018-07-17 31,353 $63.50 1,418,919 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-07-17 31,353 $0.00 31,353 $21.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
69,871 2018-08-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 608,700 Indirect By GRAT
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  2. The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.50 to $63.57.
  3. 25% of the option grant vested on 8/14/2009 (the first anniversary of the grant date of 8/14/2008), and the remaining 75% vested monthly thereafter over 36 months.